HOME >> BIOLOGY >> NEWS
New gene monitors cell division, cancer clinical applications seen

In health, most cells undergo a carefully orchestrated cell-division process in order to replicate. At the heart of this process is mitosis, in which a cell's nucleus duplicates its genetic material and divides. Precisely controlled mitosis is vital to survival, and rigorous checkpoint mechanisms are in place to ensure that each step in the process is properly executed before the cell moves on to the next step. Although not well proven, it is generally believed that many human cancers stem from checkpoint defects in mitosis.

In the July 27 issue of Nature, scientists at The Wistar Institute report identification of a new gene called chfr that establishes a previously unknown checkpoint in mitosis. Further, a laboratory survey of eight human cancer cell lines found chfr to be inactivated, through lack of expression or mutation, in four of the eight -- fully half of the cell lines studied. Mitotic checkpoint genes identified in earlier studies had been linked to cancers, too, but mutant versions had been found in only 1 or 2 percent of cancers.

"The frequency of mutations in previously identified mitotic checkpoint genes is too low to explain the incidence rates of cancers in which troubled cell division is thought to play a role," says Thanos D. Halazonetis, D.D.S., Ph.D., senior author on the study and an associate professor at Wistar. "So, the question was whether there were checkpoint genes we didn't know about and whether those were the genes suffering mutations in these cancers. What we found was a new gene and a wholly new mechanism that monitors progress through mitosis. Further, this gene was disrupted in 50 percent of the cancer cell lines we studied, much higher than the rates for other known checkpoint genes."

Halazonetis emphasizes that studies of tumors from patients will be needed to confirm that mutant chfr is as common in primary cancer cells as it is in laboratory cancer cell lines. If the findings are confirmed, however, clinical a
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
26-Jul-2000


Page: 1 2

Related biology news :

1. Imaging technique discovered at Stanford monitors cancer cell proliferation
2. Researchers call for trials of menstrual cycle monitors used for natural family planning
3. Newer design of close-up computer monitors increases ease of use
4. New technique monitors chromium contamination in groundwater
5. MIT instrument monitors molten materials
6. Researchers link failed cell division, Alzheimers disease
7. Leader in cancer treatment and prevention research honored
8. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
9. Chemical derived from vitamin-E shows early promise as cancer drug
10. New molecular link key to cellular proteins involved in cancer progression, other diseases
11. Phase II trials of second-generation antisense cancer drug planned following successful early study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2017)... 15 2017   ivWatch LLC , a medical device company ... today announced receipt of its ISO 13485 Certification, the global standard ... Organization for Standardization (ISO®). ... Model 400 Continuous Monitoring device for the early detection of IV ... "This is an important milestone for ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
Breaking Biology News(10 mins):
(Date:10/7/2017)... ... October 06, 2017 , ... ... launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available ... bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, supplementing ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech ... technology sector at their fourth annual Conference where founders, investors, innovative practitioners and ... the ELEVATE pitch competition showcasing early stage digital health and med tech companies. ...
(Date:10/5/2017)... ... October 05, 2017 , ... LabRoots , the leading ... around the world, is giving back to cancer research with a month-long promotion supporting ... Now through October 31, shoppers can use promo code PinkRibbon to get 10 percent ...
(Date:10/5/2017)... , ... October 05, 2017 , ... ... develop new applications of its Nanobind DNA/RNA extraction technology . Nanobind is ... silica on the surface and that can be used for a wide variety ...
Breaking Biology Technology:
Cached News: